|Bid||66.24 x 800|
|Ask||66.83 x 1100|
|Day's range||63.77 - 67.03|
|52-week range||63.25 - 89.70|
|Beta (5Y monthly)||0.62|
|PE ratio (TTM)||31.95|
|Earnings date||28 Jul 2022|
|Forward dividend & yield||1.16 (1.78%)|
|Ex-dividend date||02 Jun 2022|
|1y target est||88.31|
In this article we are going to estimate the intrinsic value of Baxter International Inc. ( NYSE:BAX ) by taking the...
DEERFIELD, Ill., June 08, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2022 financial results on Thursday, July 28, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information.
Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio and regulatory clearances.